PMID: 9002573Jan 1, 1997Paper

On-site availability of selected antidotes: results of a survey of Massachusetts hospitals

The American Journal of Emergency Medicine
A D Woolf, K Chrisanthus

Abstract

Hospital pharmacies in Massachusetts were surveyed to determine their patterns of stocking antidotes. Mailed questionnaires were completed by hospital pharmacy directors at 82 of 93 acute care institutions (87% response rate). Results confirmed great variability in on-site accessibility of antidotes. Only 8 of the 82 hospitals (9.8%) stocked all of 14 common antidotes inventoried by the survey. Even fewer hospital pharmacies stocked specific antidotes (eg, Crotalid anti-venin, digoxin-specific Fab antibodies, pyridoxine) in an adequate quantity to treat one poisoned adult. Larger hospitals and those with a 24-hour pharmacy were more likely to have certain antidotes than smaller institutions. We conclude that Massachusetts hospitals do not carry complete inventories of 14 common antidotes. It is important that poisoned patients be referred to medical centers with adequate toxicological care. Improved guidelines for the accessibility of antidotes need to be developed and made available to hospital pharmacies and emergency departments.

References

Jan 1, 1993·Polish Journal of Occupational Medicine and Environmental Health

❮ Previous
Next ❯

Citations

Oct 8, 2003·Toxicon : Official Journal of the International Society on Toxinology·Kiyohito NakaiMotowo Tomita
Feb 3, 1999·The American Journal of Emergency Medicine·P A StierA Burda
May 23, 2007·American Journal of Therapeutics·Anthony M BurdaChristina Hantsch Bardsley
Sep 15, 2005·Pediatric Emergency Care·Sidney M Gospe, Robert M S Bell
Apr 20, 2010·The Australian Journal of Rural Health·Lisa M NissenDarren M Roberts
Jun 14, 2013·Journal of Pharmacology & Pharmacotherapeutics·Lucas GascoVikhyat S Bebarta
Nov 30, 2011·Disaster Medicine and Public Health Preparedness·Robert S HoffmanLewis Goldfrank
Jan 9, 2014·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Robert S Hoffman
Nov 3, 2007·The Journal of Emergency Medicine·Marc Eckstein
Oct 18, 2005·The Medical Clinics of North America·Nicole L Ries, Richard C Dart
Mar 21, 2003·Journal of Toxicology. Clinical Toxicology·Rita MrvosEdward P Krenzelok
Feb 26, 2015·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·UNKNOWN American College of Medical Toxicology, UNKNOWN American Academy of Clinical Toxicology
Feb 7, 2017·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Gregory A HeindelKevin C Osterhoudt
Feb 24, 2001·Human & Experimental Toxicology·M A Higgins, R Evans
Jan 5, 2002·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·A M Burda, T Sigg
Mar 10, 2005·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Philippe LheureuxMireille Gris
May 14, 2011·International Journal of Health Services : Planning, Administration, Evaluation·Juhwan OhSang-Jun Eun
Jul 31, 2007·CJEM·Sean K GormanGillian A Willis
May 15, 2004·Prehospital and Disaster Medicine·Mark E KeimNana A Y Twum-Danso
Jan 24, 2021·European Journal of Hospital Pharmacy. Science and Practice·Yvonne Elisabeth LaoKnut Erik Hovda
May 8, 2007·Emergency Medicine Clinics of North America·Timothy B EricksonJenny J Lu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved